Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrochlorothiazide + amiloride is a fixed-dose combination of two diuretics used primarily to treat high blood pressure (hypertension) and fluid retention (edema), especially in patients at risk for low potassium levels. Hydrochlorothiazide is a thiazide diuretic that increases the excretion of sodium and water by inhibiting sodium reabsorption in the distal tubules of the kidney, which helps lower blood pressure but can cause potassium loss. Amiloride is a potassium-sparing diuretic that acts on the distal renal tubules to inhibit sodium reabsorption while reducing potassium excretion, thereby counteracting hypokalemia caused by thiazides. The combination provides effective antihypertensive action while minimizing disturbances in serum potassium[1][2][3][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hydrochlorothiazide + amiloride.